Education
About Us
Working with TipRanks
Follow Us
Tami Tillotson Martin Insider Profile
4 Followers
Tami Tillotson Martin, Sr. V.P., Regulatory Affairs at Supernus Pharmaceuticals, holds 86.93K shares in Supernus Pharmaceuticals (Ticker: SUPN).
Tami Tillotson Martin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tami Tillotson Martin's holdings
Insider Roles
Sr. V.P., Regulatory Affairs
Roles that Tami Tillotson Martin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 01, 2023 - Sep 01, 2024
Return:-8.20%
The most profitable trade made by Tami Tillotson Martin
Tami Tillotson Martin's Trading History
List of latest transactions for each holding click on a transaction to see Tami Tillotson Martin's performance on stock
You May Also Like
Tami Tillotson Martin insider profile FAQ
What is the percentage of profitable transactions made by Tami Tillotson Martin?
The percentage of profitable transactions made by Tami Tillotson Martin is ―.
What is the average return per transaction made by Tami Tillotson Martin?
The average return per transaction made by Tami Tillotson Martin is ―.
What stocks does Tami Tillotson Martin hold?
Tami Tillotson Martin holds: SUPN stocks.
What was Tami Tillotson Martin’s latest transaction?
Tami Tillotson Martin latest transaction was an Uninformative Buy of ―.
What was Tami Tillotson Martin's most profitable transaction?
Tami Tillotson Martin’s most profitable transaction was an Informative Sell of SUPN stock on September 1, 2023. The return on the trade was -8.20%.
What is Tami Tillotson Martin's role in Supernus Pharmaceuticals?
Tami Tillotson Martin's role in Supernus Pharmaceuticals is Sr. V.P., Regulatory Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.